Oxford Biomedica Forecast, price target & analysts
Oxford Biomedica Target price 2026 - Analyst rating & recommendation
Oxford Biomedica Classifications & Recommendation
Oxford Biomedica Price Target
| Target Price | £7.94 |
| Price | £4.58 |
| Potential |
73.46%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Oxford Biomedica 2027 .
The average Oxford Biomedica target price is £7.94.
This is
73.46%
register free of charge
£9.45
106.56%
register free of charge
£5.13
12.15%
register free of charge
|
|
| A rating was issued by 16 analysts: 12 Analysts recommend Oxford Biomedica to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Oxford Biomedica stock has an average upside potential 2027 of
73.46%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million £ | 168.74 | 205.98 |
| 31.01% | 22.07% | |
| EBITDA Margin | -7.44% | 6.22% |
| 43.20% | 183.56% | |
| Net Margin | -17.86% | -11.91% |
| 46.75% | 33.30% |
11 Analysts have issued a sales forecast Oxford Biomedica 2026 . The average Oxford Biomedica sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Oxford Biomedica EBITDA forecast 2026. The average Oxford Biomedica EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Oxford Biomedica Analysts have issued a net profit forecast 2026. The average Oxford Biomedica net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share £ | -0.27 | -0.20 |
| 35.71% | 25.93% | |
| P/E | negative | |
| EV/Sales | 2.94 |
10 Analysts have issued a Oxford Biomedica forecast for earnings per share. The average Oxford Biomedica EPS is
This results in the following potential growth metrics and future valuations:
Oxford Biomedica...
Current Oxford Biomedica Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital Markets |
Locked
➜
Locked
|
Locked | Jun 24 2026 |
| RBC Capital Markets |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Mar 23 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Mar 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital Markets:
Locked
➜
Locked
|
Jun 24 2026 |
|
Locked
RBC Capital Markets:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Mar 23 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Mar 11 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
